FIND CLINICAL TRIALS

 
 

PD-1 = PROGRAMMED CELL DEATH-1

 
 
 

Incyte is developing a PD-1 antibody.

PD-1 is a protein expressed on multiple immune cells, including T cells, and acts as a key checkpoint in tumor-induced immune suppression.

Activation of PD-1 can reduce effector T-cell activity and facilitate regulatory T-cell formation, while down-regulating expression of anti-apoptotic molecules and pro-inflammatory cytokines. Blocking PD-1 can increase antitumor immunity through enhancing T-cell activity.

MOLECULE LIBRARY